Savita Pahwa1, Steven Deeks2, Shimian Zou3, Natalie Tomitch4, Leia Miller-Novak5, Elisabet Caler3, Amy Justice6, Ned Sacktor7, Dana Gabuzda8, Peter W Hunt2, Todd Brown7, Ann Kurth9, Stefan Baral10, Michael Mugavero11, Kenneth H Mayer12, Emily Mendenhall13, Roger Detels14, Vincent Mutabazi15. 1. University of Miami Miller School of Medicine, Miami, FL. 2. University of California, San Francisco, CA. 3. National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD. 4. Office of AIDS Research (OAR), Bethesda, MD. 5. National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD. 6. Yale University School of Medicine, New Haven, CT. 7. Johns Hopkins University, School of Medicine, Baltimore, MD. 8. Dana-Farber Cancer Institute, Boston, MA. 9. Yale University, School of Nursing, Orange, CT. 10. Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD. 11. University of Alabama at Birmingham, Birmingham, AL. 12. Harvard University, Medical School and Fenway Health, Boston, MA. 13. Georgetown University, Washington, DC. 14. University of California, Los Angeles, CA; and. 15. Regional Alliance Sustainable Development, Kigali, Rwanda.
Abstract
BACKGROUND: With potent antiretroviral therapy and simplified regimens, people living with HIV (PWH) are achieving near-normal lifespans but not necessarily a normal health span or healthy aging. PWH have a higher than expected risk of developing a number of non-AIDS comorbidities, coinfections, and complications (CCC), often against a background of stigma, poverty, and isolation. SETTING: To gain a better understanding of research needs for HIV-associated CCC, the NIH convened a 2-day workshop (HIV-associated CCC, or HIV ACTION). METHODS: A cross-institute NIH planning committee identified 6 key research areas: epidemiology and population research, pathogenesis and basic science research, clinical research, implementation science research, syndemics research and international research in low and middle income countries. Investigators were selected to lead working groups (WGs) to assess the state-of-the-art and identify 3-5 priority areas in each field before the workshop. A 2-day program at the NIH was developed which included presentations by invited experts and WG members. RESULTS: Over 400 participants attended the workshop. After general and individual WG discussions, the most pressing gaps, questions, or proposed action items were identified. Priority lists of pressing research issues were presented by cochairs of each WG. A detailed report is posted at the NHLBI website. This article reports the streamlined priority list and a summary of WG discussions to inform investigators of current priorities in the field. CONCLUSION: Collaborative efforts of many disciplines are needed to improve the health and wellbeing of PWH. Several common themes emerged across WG representing potential priorities for investigators and recommendations for the NIH.
BACKGROUND: With potent antiretroviral therapy and simplified regimens, people living with HIV (PWH) are achieving near-normal lifespans but not necessarily a normal health span or healthy aging. PWH have a higher than expected risk of developing a number of non-AIDS comorbidities, coinfections, and complications (CCC), often against a background of stigma, poverty, and isolation. SETTING: To gain a better understanding of research needs for HIV-associated CCC, the NIH convened a 2-day workshop (HIV-associated CCC, or HIV ACTION). METHODS: A cross-institute NIH planning committee identified 6 key research areas: epidemiology and population research, pathogenesis and basic science research, clinical research, implementation science research, syndemics research and international research in low and middle income countries. Investigators were selected to lead working groups (WGs) to assess the state-of-the-art and identify 3-5 priority areas in each field before the workshop. A 2-day program at the NIH was developed which included presentations by invited experts and WG members. RESULTS: Over 400 participants attended the workshop. After general and individual WG discussions, the most pressing gaps, questions, or proposed action items were identified. Priority lists of pressing research issues were presented by cochairs of each WG. A detailed report is posted at the NHLBI website. This article reports the streamlined priority list and a summary of WG discussions to inform investigators of current priorities in the field. CONCLUSION: Collaborative efforts of many disciplines are needed to improve the health and wellbeing of PWH. Several common themes emerged across WG representing potential priorities for investigators and recommendations for the NIH.
Authors: Gabriel Chamie; Matthew D Hickey; Dalsone Kwarisiima; James Ayieko; Moses R Kamya; Diane V Havlir Journal: Curr HIV/AIDS Rep Date: 2020-08 Impact factor: 5.071
Authors: Jamie N Justice; Luigi Ferrucci; Anne B Newman; Vanita R Aroda; Judy L Bahnson; Jasmin Divers; Mark A Espeland; Santica Marcovina; Michael N Pollak; Stephen B Kritchevsky; Nir Barzilai; George A Kuchel Journal: Geroscience Date: 2018-08-27 Impact factor: 7.713
Authors: Joyonna Carrie Gamble-George; Christopher T Longenecker; Allison R Webel; David H Au; Arleen F Brown; Hayden Bosworth; Kristina Crothers; William E Cunningham; Kevin A Fiscella; Alison B Hamilton; Christian D Helfrich; Joseph A Ladapo; Amneris Luque; Jonathan N Tobin; Gail E Wyatt Journal: Prog Cardiovasc Dis Date: 2020-03-19 Impact factor: 8.194
Authors: Keri N Althoff; Kelly A Gebo; Richard D Moore; Cynthia M Boyd; Amy C Justice; Cherise Wong; Gregory M Lucas; Marina B Klein; Mari M Kitahata; Heidi Crane; Michael J Silverberg; M John Gill; William Christopher Mathews; Robert Dubrow; Michael A Horberg; Charles S Rabkin; Daniel B Klein; Vincent Lo Re; Timothy R Sterling; Fidel A Desir; Kenneth Lichtenstein; James Willig; Anita R Rachlis; Gregory D Kirk; Kathryn Anastos; Frank J Palella; Jennifer E Thorne; Joseph Eron; Lisa P Jacobson; Sonia Napravnik; Chad Achenbach; Angel M Mayor; Pragna Patel; Kate Buchacz; Yuezhou Jing; Stephen J Gange Journal: Lancet HIV Date: 2019-01-22 Impact factor: 12.767
Authors: Leah H Rubin; Ava G Neijna; Qiuhu Shi; Donald R Hoover; Bani Tamraz; Kathryn Anastos; Andrew Edmonds; Margaret A Fischl; Deborah Gustafson; Pauline M Maki; Daniel Merenstein; Anandi N Sheth; Gayle Springer; David Vance; Kathleen M Weber; Anjali Sharma Journal: AIDS Res Hum Retroviruses Date: 2022-04-26 Impact factor: 1.723